Fortfahren mit
Größe auswählen
| Größe/SKU | Verfügbarkeit | Preis |
|---|---|---|
100 mg | Warenkorb auf Verfügbarkeit prüfen | € 356,00 |
Über diesen Artikel
grade
pharmaceutical primary standard
agency
USP
API family
methionine & derivatives
manufacturer/tradename
USP
application(s)
pharmaceutical
pharmaceutical (small molecule)
format
neat
SMILES string
C[Se]CC[C@H](N)C(O)=O
InChI
1S/C5H11NO2Se/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1
InChI key
RJFAYQIBOAGBLC-BYPYZUCNSA-N
General description
For further information and support please go to the website of the issuing Pharmacopoeia.
Application
Analysis Note
Other Notes
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description United States Pharmacopeia (USP) Reference Standard | description L Selenomethionine increases the expression of glutathione peroxidase. | description certified reference material, pharmaceutical secondary standard | description ≥98% (TLC), powder |
| manufacturer/tradename USP | manufacturer/tradename Calbiochem® | manufacturer/tradename - | manufacturer/tradename - |
| grade pharmaceutical primary standard | grade - | grade pharmaceutical secondary standard, certified reference material | grade - |
| format neat | format - | format - | format - |
| application(s) pharmaceutical (small molecule) | application(s) - | application(s) pharmaceutical | application(s) - |
| agency USP | agency - | agency traceable to USP 1611955 | agency - |
| API family methionine & derivatives | API family - | API family - | API family - |
Signalwort
Danger
Gefahrencodes
Sicherheitshinweise
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - STOT RE 2
Lagerklasse
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
Was ist los?
WGK 3
Flammpunkt (°F)
250.3 - 346.3 °F
Flammpunkt (°C)
121.3 - 174.6 °C
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.




